TAK-748

Takeda Eyes 12 New Drug Approvals by 2024, Hemophilia Gene Therapy May Not be a Competitor
BioSpace
Wed, 01/22/20 - 11:08 am
Takeda
drug approvals
hemophilia A
TAK-754
TAK-748